Abstract
Objective: To determine if the same systematic alteration of serum values seen for alpha-fetoprotein (AFP) in diabetic patients is also seen for β- hCG and unconjugated estriol (uE3). Methods: Serum AFP, β-hCG, and uE3 results were obtained in 18,639 patients for whom complete follow-up information was obtained. Patients were divided into euglycemic (n = 18,088), insulin-requiring diabetics (n = 104), and non-insulin-requiring diabetics (n = 437), a well as by race. Results: The 20% adjustment used for AFP appropriately corrects serum values. No such systematic variation is seen for either β-hCG or uE3 by glycemic status or race. Conclusion: No adjustment for β-hCG or uE3 is necessary for diabetes for biochemical screening programs.
Original language | English |
---|---|
Pages (from-to) | 20-22 |
Number of pages | 3 |
Journal | Journal of the Society for Gynecologic Investigation |
Volume | 3 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1996 |
Externally published | Yes |
Keywords
- Insulin
- diabetes
- multiple marker biochemical screening
- screening programs